KV

Krishnakumar Velakkathaleth

Active Director Designated Partner DIN 10893242
DIN 10893242 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishnakumar Velakkathaleth

Data last updated:

Krishnakumar Velakkathaleth is a Designated Partner at Kramelt Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 10893242
Primary Designation Designated Partner
Industry Pharma
First Appointment 01 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 Jan 20252025Active

Board colleagues of Krishnakumar Velakkathaleth

NameDINCompanyDesignation
Jisha Balachandran09096620Kramelt Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Kramelt Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Krishnakumar Velakkathaleth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishnakumar Velakkathaleth

Krishnakumar Velakkathaleth currently holds 1 directorship: Kramelt Pharmaceuticals Llp (Designated Partner, since 01 Jan 2025).

Krishnakumar Velakkathaleth was first appointed on 01 Jan 2025 as Designated Partner at Kramelt Pharmaceuticals Llp.

The current boards of Krishnakumar Velakkathaleth's companies include Jisha Balachandran (Kramelt Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available